285130 — SK Chemicals Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩1tn
- KR₩1tn
- KR₩2tn
- 27
- 59
- 55
- 43
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 272,650 | 426,693 | 2,049,772 | 1,714,471 | 1,422,954 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 171,237 | 233,885 | 364,588 | 249,940 | 179,998 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 792,023 | 923,286 | 2,784,059 | 2,518,694 | 2,204,427 |
Net Property, Plant And Equipment | 1,223,248 | 1,086,101 | 1,014,632 | 1,221,740 | 1,636,951 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 2,131,709 | 2,119,967 | 3,955,632 | 3,945,683 | 4,158,775 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 718,865 | 645,679 | 1,086,649 | 1,058,819 | 830,211 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,416,081 | 1,167,089 | 1,902,091 | 1,798,984 | 2,040,071 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 715,629 | 952,878 | 2,053,542 | 2,146,699 | 2,118,704 |
Total Liabilities & Shareholders' Equity | 2,131,709 | 2,119,967 | 3,955,632 | 3,945,683 | 4,158,775 |
Total Common Shares Outstanding |